US 11479772
Thiomorpholino oligonucleotides for the treatment of muscular dystrophy
granted A61KA61K31/7115A61K45/06
Quick answer
US patent 11479772 (Thiomorpholino oligonucleotides for the treatment of muscular dystrophy) held by The Regents of the University of Colorado expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7115, A61K45/06, A61K47/645, A61K9/0019